Challenges of Scalability in High Potency Manufacturing

This technical report discusses the challenges associated with scalability in the manufacturing of drug products containing high potency active pharmaceutical ingredients (HPAPIs). A panel of experts outlines the importance of reducing risk and ensuring consistent quality during the scaling process. The report details the complexities of transitioning from small-scale to large-scale production, emphasizing the need for robust manufacturing processes and effective knowledge transfer between contract development and manufacturing organizations (CDMOs) and sponsor companies. It also highlights the critical role of containment requirements in ensuring operator safety and product quality. The report presents insights into flexible facility design by CDMOs to accommodate varying production scales and underscores the necessity of collaboration among stakeholders to develop tailored manufacturing solutions. Additionally, it addresses the financial, technological, and regulatory risks involved in drug development and the strategic advantages of outsourcing to CDMOs. Overall, the report provides a comprehensive examination of the factors influencing the scalability of high potency drug manufacturing.